Detalhe da pesquisa
1.
Genetic markers of bevacizumab-induced hypertension.
Angiogenesis
; 17(3): 685-94, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24558090
2.
Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy.
Angiogenesis
; 17(4): 909-20, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25012543
3.
Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer.
Breast Cancer Res
; 11(4): 208, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19744307
4.
Bevacizumab in breast cancer: fundamental questions remain.
Lancet Oncol
; 14(2): 99-101, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23369679
5.
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer.
Cancer Chemother Pharmacol
; 58(6): 809-15, 2006 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-16528527
6.
Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice.
Int J Oncol
; 25(4): 937-43, 2004 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-15375543
7.
Quality of life in women with advanced breast cancer treated with docetaxel.
Clin Breast Cancer
; 5(3): 216-22; discussion 223-4, 2004 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-15335454
8.
Safety of bevacizumab in metastatic breast cancer patients undergoing surgery.
Eur J Cancer
; 48(4): 475-81, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22196033
9.
Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: results from AVADO.
Eur J Cancer
; 47(16): 2387-95, 2011 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-21757334
10.
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.
J Clin Oncol
; 28(20): 3239-47, 2010 Jul 10.
Artigo
Inglês
| MEDLINE | ID: mdl-20498403
11.
Use of endomyocardial biopsy to assess anthracycline-induced cardiotoxicity.
Lancet Oncol
; 6(2): 67, 2005 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-15683815
12.
Clinical and pathological absence of cardiotoxicity after liposomal doxorubicin.
Lancet Oncol
; 5(9): 575-7, 2004 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-15337488